Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioForce Nanosciences Holdings, Inc. BFNH

Full chart Compare
Set alert

Price alert · BFNH

All alert types
6.85 USD 0.00 (+0.00%)

Nov 4, 2026, 1:59 PM EST

6.85 Day range 6.85
0.18 52-week range 10.99
YTD
+1,081.03%
1 year
+892.75%

Financial health

Altman Z-Score

1531.71 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -14.9×
FY 2016: -139×FY 2017: -2857×FY 2018: -1239×FY 2019: -267×FY 2020: -0.0×FY 2021: -70.2×FY 2022: -120×FY 2023: -125×FY 2024: -20.3×FY 2025: -14.9×
FY 2016 5y median -70.2× FY 2025
P/S 0.0×
FY 2016: 102×FY 2017: 20310×FY 2018: 5100×FY 2019: 687×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -31.1×
FY 2016: -40.3×FY 2017: 11143×FY 2018: 2791×FY 2019: 258×FY 2020: -17.2×FY 2021: -40.8×FY 2022: -43.2×FY 2023: -32.3×FY 2024: -4.3×FY 2025: -31.1×
FY 2016 5y median -32.3× FY 2025
P/FCF -296×
FY 2016: 483×FY 2017: -3529×FY 2018: -1332×FY 2019: -501×FY 2020: -77.3×FY 2021: -452×FY 2022: -852×FY 2023: -1260×FY 2024: -163×FY 2025: -296×
FY 2016 5y median -452× FY 2025
EV/EBITDA -39.3×
FY 2016: -145×FY 2017: -2923×FY 2018: -1246×FY 2019: -261×FY 2020: -0.0×FY 2021: -70.2×FY 2022: -120×FY 2023: 0.0×FY 2024: -20.9×FY 2025: -39.3×
FY 2016 5y median -39.3× FY 2025
EV/Sales 0.0×
FY 2016: 101×FY 2017: 20306×FY 2018: 5098×FY 2019: 684×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -0.3%
FY 2016: 0.2%FY 2017: -0.0%FY 2018: -0.1%FY 2019: -0.2%FY 2020: -1.3%FY 2021: -0.2%FY 2022: -0.1%FY 2023: -0.1%FY 2024: -0.6%FY 2025: -0.3%
FY 2016 5y median -0.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 27.3%FY 2017: 27.9%FY 2018: 28.6%FY 2019: 24.5%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -69.2%FY 2017: -694.7%FY 2018: -409.2%FY 2019: -261.8%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -69.2%FY 2017: -694.7%FY 2018: -415.3%FY 2019: -261.8%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 208.9%
FY 2016: 27.3%FY 2017: -381.1%FY 2018: -227.3%FY 2019: -98.4%FY 2020: 44013.6%FY 2021: 58.2%FY 2022: 36.0%FY 2023: 25.9%FY 2024: 21.3%FY 2025: 208.9%
FY 2016 5y median 36.0% FY 2025
ROIC 79.2%
FY 2016: -250.0%FY 2017: -381.1%FY 2018: -223.9%FY 2019: -98.4%FY 2020: 44013.6%FY 2021: 58.2%FY 2022: 36.0%FY 2023: 25.9%FY 2024: 24.2%FY 2025: 79.2%
FY 2016 5y median 36.0% FY 2025
ROA -164370.4%
FY 2016: -34.8%FY 2017: -149.5%FY 2018: -192.8%FY 2019: -79.0%FY 2020: -397362.5%FY 2021: -4503.9%FY 2022: -66146.3%FY 2023: -73973.8%FY 2024: -56895.2%FY 2025: -164370.4%
FY 2016 5y median -66146.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 35.8%FY 2017: -45.5%FY 2018: 262.4%FY 2019: 9.0%FY 2020: -100.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 0.1%
FY 2016: -128.5%FY 2017: -447.3%FY 2018: -113.5%FY 2019: 30.3%FY 2020: -340285.4%FY 2021: 99.7%FY 2022: 3.3%FY 2023: 2.8%FY 2024: -3.9%FY 2025: 0.1%
FY 2016 FY 2025
EPS (diluted) -131.5%
FY 2016: -33.3%FY 2017: -425.0%FY 2018: 57.1%FY 2019: -233.3%FY 2020: -323900.0%FY 2021: 99.8%FY 2022: 2.9%FY 2023: 3.0%FY 2024: -4.3%FY 2025: -131.5%
FY 2016 FY 2025
Free Cash Flow -6.4%
FY 2016: 189289.2%FY 2017: -1579.9%FY 2018: -141.2%FY 2019: 61.0%FY 2020: -228.9%FY 2021: 3.0%FY 2022: 12.1%FY 2023: 31.7%FY 2024: -31.2%FY 2025: -6.4%
FY 2016 FY 2025

Financial Health

Current Ratio 0.0×
FY 2016: 1.2×FY 2017: 1.6×FY 2018: 6.6×FY 2019: 5.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Quick Ratio 0.0×
FY 2016: 1.2×FY 2017: 1.8×FY 2018: 6.6×FY 2019: 5.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.2×FY 2021: -0.1×FY 2022: -0.1×FY 2023: -0.1×FY 2024: -0.1×FY 2025: 0.0×
FY 2016 5y median -0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2016: 2.5×FY 2017: 0.5×FY 2018: 0.4×FY 2019: 1.1×FY 2020: -0.0×FY 2021: -0.2×FY 2022: -0.4×FY 2023: 0.0×FY 2024: -0.6×FY 2025: 0.0×
FY 2016 5y median -0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31